Joint replacement in human immunodeficiency virus-infected patients

Journal of the Chinese Medical Association

Volumn 75, Issue 11, 2012, Pages 595-599

  Wang, Ta I ^a   Chen, Cheng Fong ^a,b   Chen, Wei Ming ^a,b   Chiang, Chao Ching ^a,b   Huang, Ching Kuei ^a,b   Liu, Chien Lin ^a,b   Chen, Tain Hsiung ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Arthroplasty; HIV; Infection; Joint replacement; Osteonecrosis

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; CEPHALOSPORIN; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; JOINT PROSTHESIS; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; RISK; SHOULDER HEMIARTHROPLASTY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADULT; ARTHROPLASTY, REPLACEMENT; HIV INFECTIONS; HUMANS; INFECTION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 84869490887     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.08.021     Document Type: Article

References (34)

1. Tehranzadeh J., Ter-Oganesyan R.R., Steinbach L.S. Musculoskeletal disorders associated with HIV infection and AIDS. Part II: non-infectious musculoskeletal conditions. Skeletal Radiol 2004, 33:311-320.
2. Bonfanti P., Grabbuti A., Carradori S., Pusterla L., Parrazini F., Landonio S., et al. Osteonecrosis in protease inhibitor-treated patients. Orthopedics 2001, 24:271-272.
3. Scribner A.N., Troia-Cancio P.V., Cox B.A., Marcantonio D., Hamid F., Keiser P., et al. Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr 2000, 25:19-25.
4. Valencia M.E., Barreiro P., Soriano V., Blanco F., Moreno V., Lahoz J.G. Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: study of seven cases. HIV Clin Trials 2003, 4:132-136.
5. Keruly J.C., Chaisson R.E., Moore R.D. Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J Acquir Immune Defic Syndr 2001, 28:101-102.
6. Ries M.D., Barcohana B., Davidson A., Jergesen H.E., Paiement G.D. Association between human immunodeficiency virus and osteonecrosis of the femoral head. J Arthroplasty 2002, 17:135-139.
7. Hodak SP, Fluhme D, Kumar P, Nascone J, Evans B, Timpone JG. Avascular necrosis and protease inhibitor exposure. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999.
8. Meyer D., Behrens G., Schmidt R.E., Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS 1999, 13:1147-1148.
9. Mammen-Prasad EK, Bishburg E. Avascular necrosis in HIV infected patients. Abstracts of the Infectious Diseases Society of America 37th Annual Meeting, Philadelphia, 1999.
10. Rosenberg Z.F., Fauci A.S. Immunopathogenesis of HIV infection. FASEB J 1991, 5:2832-2890.
11. Lane H.C., Masur H., Edgar L.C., Whalen G., Rock A.H., Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983, 309:453-458.
12. Teeuwsen V.J., Siebelink K.H., de Wolf F., Goudsmit J., UytdeHaag F., Osterhaus A. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. AIDS 1990, 4:77-81.
13. Schnittman S.M., Greenhouse J.J., Psallidopoulos M.C., Baseler M., Salzman N.P., Fauci A.S., et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990, 113:438-443.
14. van Noesel C.J., Gruters R.A., Terpstra F.G., Schellekens P.T., van Lier R.A., Miedema F. Functional and phenotypic evidence for selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 1990, 86:293-299.
15. Rossol S., Gianni G., Rossol-Voth R., Gallati H., Müller W.E.G., Meyer zum Büschenfelde K.H. Cytokine-mediated regulation of monocyte/macrophage cytotoxicity in human immunodeficiency virus-1 infection. Med Microbiol Immunol 1992, 181:267-281.
16. Seltzer D.G., McAuliffe J., Campbell D.R., Burkhalter W.E. AIDS in the hand patient: the team approach. Hand Clin 1991, 7:433-445.
17. Biviji A.A., Paiement G.D., Steinbach L.S. Musculoskeletal manifestations of human immunodeficiency virus infection. J Am Acad Orthop Surg 2002, 10:312-320.
18. Plate A.M., Boyle B.A. Musculoskeletal manifestations of HIV infection. AIDS Read 2003, 13:62-76.
19. Cuellar M.L. HIV infection-associated inflammatory musculoskeletal disorders. Rheum Dis Clin North Am 1998, 24:403-421.
20. Tehranzadeh J., T M Musculoskeletal imaging in AIDS. Medical radiology-Diagnostic imaging and radiation oncology. Radiology of AIDS. A practical approach 2001, 169-197. Springer, Berlin Heidelberg New York.
21. Tehranzadeh J., O'Malley P., Rafii M. The spectrum of osteoarticular and soft tissue changes in patients with human immunodeficiency virus (HIV) infection. Crit Rev Diagn Imaging 1996, 37:305-347.
22. Steinbach L.S., Tehranzadeh J., Fleckenstein J.L., Vanarthos W.J., Pais M.J. Human immunodeficiency virus infection: musculoskeletal manifestations. Radiology 1993, 186:833-838.
23. Carr A., Samaras K., Thorisdottir A., Kaufmann G.R., Chisholm D.J., Cooper D.A. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999, 353:2093-2099.
24. Jacobs B. Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res 1978, 130:51-67.
25. Belmonte M.A., Garcia-Portales R., Doménech I., Fernández-Nebro A., Camps M.T., De Ramón E. Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. J Rheumatol 1993, 20:1425-1428.
26. Olivé A., Queralt C., Sirera G., Centelles M., Force L. Osteonecrosis and HIV infection: 4 more cases. J Rheumatol 1998, 25:1243-1244.
27. Solomon G., Brancato L., Winchester R. An approach to the human immunodeficiency virus-positive patient with a spondyloarthropathic disease. Rheum Dis Clin North Am 1991, 17:43-58.
28. Cohen A.J., Philips T.M., Kessler C.M. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med 1986, 104:175-180.
29. Canoso R.T., Zon L.I., Groopman J.E. Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987, 65:495-498.
30. Bloom E.J., Abrams D.I., Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986, 256:491-493.
31. Stimmler M.M., Quismorio F.P., McGehee W.G., Boylen T., Sharma O.P. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 1989, 149:1833-1835.
32. Olapade-Olaopa E.O., Salami M.A., Afolabi A.O. HIV/AIDS and the surgeon. Afr J Med Med Sci 2006, 35(Suppl):77-83.
33. Davies C.G., Khan M.N., Ghauri A.S., Ranaboldo C.J. Blood and body fluid splashes during surgery - the need for eye protection and masks. Ann R Coll Surg Engl 2007, 89:770-772.
34. Marasco S., Woods S. The risk of eye splash injuries in surgery. Aust N Z J Surg 1998, 68:785-787.